Literature DB >> 7996007

Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia.

C Hol1, E E Van Dijke, C M Verduin, J Verhoef, H van Dijk.   

Abstract

Resistance of microorganisms to antimicrobial agents is an increasing problem in the treatment of infectious diseases. In mixed infections, an interesting development can arise when one organism protects another from being killed by an antibiotic. Unfortunately, in the case of respiratory tract infections, experimental evidence of this development is poor. In this study, mice intranasally infected with a lethal number of pneumococci and treated with a curative dose of penicillin or amoxicillin died from pneumococcal pneumonia when they were coinoculated with beta-lactamase-producing Moraxella catarrhalis. beta-lactamase-negative M. catarrhalis did not show a similar indirect pathogenic effect. Treatment with a combination of amoxicillin and the beta-lactamase inhibitor clavulanic acid was not affected by beta-lactamase-producing M. catarrhalis. These findings help explain antibiotic failure in respiratory tract infections, even though the causative microorganism is sensitive to the antibiotic in vitro.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7996007     DOI: 10.1093/infdis/170.6.1613

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.

Authors:  Franz-Josef Schmitz; Andreas Beeck; Mirella Perdikouli; Mechthild Boos; Susanne Mayer; Sybille Scheuring; Karl Köhrer; Jan Verhoef; Ad C Fluit
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  Interaction of Streptococcus pneumoniae and Moraxella catarrhalis: investigation of the indirect pathogenic role of beta-lactamase-producing moraxellae by use of a continuous-culture biofilm system.

Authors:  R K Budhani; J K Struthers
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

3.  Moraxella catarrhalis outer membrane vesicles carry β-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin.

Authors:  Viveka Schaar; Therése Nordström; Matthias Mörgelin; Kristian Riesbeck
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

4.  Moraxella (Branhamella) catarrhalis BRO beta-lactamase: a lipoprotein of gram-positive origin?

Authors:  H J Bootsma; P C Aerts; G Posthuma; T Harmsen; J Verhoef; H van Dijk; F R Mooi
Journal:  J Bacteriol       Date:  1999-08       Impact factor: 3.490

5.  Comparative analysis and supragenome modeling of twelve Moraxella catarrhalis clinical isolates.

Authors:  Jeremiah J Davie; Josh Earl; Stefan P W de Vries; Azad Ahmed; Fen Z Hu; Hester J Bootsma; Kim Stol; Peter W M Hermans; Robert M Wadowsky; Garth D Ehrlich; John P Hays; Anthony A Campagnari
Journal:  BMC Genomics       Date:  2011-01-26       Impact factor: 3.969

Review 6.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

7.  Divergent mechanisms for passive pneumococcal resistance to β-lactam antibiotics in the presence of Haemophilus influenzae.

Authors:  Kristin E D Weimer; Richard A Juneau; Kyle A Murrah; Bing Pang; Chelsie E Armbruster; Stephen H Richardson; W Edward Swords
Journal:  J Infect Dis       Date:  2011-01-10       Impact factor: 5.226

8.  Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis.

Authors:  H J Bootsma; H van Dijk; J Verhoef; A Fleer; F R Mooi
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

9.  Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in polymicrobial otitis media occurs via interspecies quorum signaling.

Authors:  Chelsie E Armbruster; Wenzhou Hong; Bing Pang; Kristin E D Weimer; Richard A Juneau; James Turner; W Edward Swords
Journal:  MBio       Date:  2010-07-06       Impact factor: 7.867

Review 10.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.